Last reviewed · How we verify

NCT04364126: HOBiT

Home Blood Pressure Monitoring in Kidney Transplant Recipients

Terminated NA Last updated 21 January 2026
What this trial tests

NA trial testing Home blood pressure apparatus in Hypertension in 21 participants. Terminated before completion.

Timeline
15 December 2022
Primary endpoint
3 February 2025
1 January 2026

Quick facts

Lead sponsorOslo University Hospital
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment21
Start date15 December 2022
Primary completion3 February 2025
Estimated completion1 January 2026
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

Oslo University Hospital

Who can join

18 and older, any sex, with Hypertension or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized controlled study of home blood pressure monitoring in kidney transplant recipients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other Oslo University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04364126.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing